Activa Capital buys pharma business

French mid-market private equity firm Activa Capital has acquired a majority stake in Delpharm, a pharmaceutical contract manufacturing outsourcing (CMO) firm.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this